Media Misrepresents Severity of Pradaxa Side Effects
By John Curran
Bloomberg News generally has quality business articles, but a recent one on Pradaxa side effects and the legal claims that have come up as a result exemplifies some key mistakes the media can make when talking about pharmaceuticals.
For example, when noting that Pradaxa side effects were glossed over because scientists found it was more effective than generic options, reporters did not mention that the difference was slight and the methodology was questionable. It also mischaracterized the centralization of Pradaxa multidistrict litigation (MDL) attorneys.
The reason that there are more than 150 Pradaxa lawsuits in a single setting is because it allows Pradaxa internal bleeding side effects victims to benefit from shared testimony without having to share in a class action lawsuit settlement. In addition, the FDA received hundreds of fatal reports regarding Pradaxa in 2011. It makes little sense to note that manufacturer Boehringer Ingelheim admitted to 260 Pradaxa deaths around the globe when the FDA’s European equivalent reported 256 in a single year.
Pradaxa internal bleeding side effects are so dangerous because the ability to reverse hemorrhaging is so difficult, if not impossible. However, while it is important for news outlets to cover the problems that the drug has had, errors that appear can cause confusion among readers. Some may wonder if Pradaxa is so much more effective than warfarin that it is worth the risks of bleeding out.
Unfortunately, it is also of little solace to families of people who have dealt with Pradaxa bleeding and hemorrhage side effects. The onset can be extremely rapid, which is another reason why these cases are often fatal, according to medical researchers and emergency room personnel. Worse, given the average deaths per year attributed to Pradaxa, it’s possible that close to one thousand people will be dead before the Pradaxa lawsuit bellwether trial in March 2014.
For those who have suffered from Pradaxa hemorrhage or internal bleeding side effects or their loved ones, legal options are available. Experienced Pradaxa MDL attorneys are currently investigating claims and scientific research to establish claims against manufacturer Boehringer Ingelheim. Visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation to learn more.
Filling out the short form there entitles one to a free legal consultation to establish the eligibility to pursue a claim against the drug maker. It costs nothing, but could be one of the few avenues to provide solace to some traumatized families looking for answers in the wake of Pradaxa bleeding conditions.
Updated December 26th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
